Syndax Pharmaceuticals, Inc. (SNDX)
NASDAQ: SNDX · Real-Time Price · USD
21.94
+0.63 (2.96%)
Jun 29, 2026, 1:07 PM EDT - Market open
Syndax Pharmaceuticals Market Cap
Syndax Pharmaceuticals has a market cap or net worth of $1.94 billion as of June 29, 2026. Its market cap has increased by 111.75% in one year.
Market Cap
1.94B
Enterprise Value
1.84B
1-Year Change
111.75%
Ranking
Category
Stock Price
$21.94
Market Cap Chart
Since March 3, 2016, Syndax Pharmaceuticals's market cap has increased from $208.60M to $1.94B, an increase of 831.98%. That is a compound annual growth rate of 24.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 29, 2026 | 1.94B | 6.46% |
| Dec 31, 2025 | 1.83B | 61.83% |
| Dec 31, 2024 | 1.13B | -25.02% |
| Dec 29, 2023 | 1.50B | -1.81% |
| Dec 30, 2022 | 1.53B | 41.76% |
| Dec 31, 2021 | 1.08B | 18.96% |
| Dec 31, 2020 | 908.90M | 281.41% |
| Dec 31, 2019 | 238.30M | 115.66% |
| Dec 31, 2018 | 110.50M | -48.29% |
| Dec 29, 2017 | 213.70M | 63.88% |
| Dec 30, 2016 | 130.40M | -37.49% |
| Mar 3, 2016 | 208.60M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AtaiBeckley | 1.95B |
| GH Research | 1.94B |
| Lakefront Biotherapeutics NV | 1.93B |
| Rapport Therapeutics | 1.92B |
| Sionna Therapeutics | 1.90B |
| Iovance Biotherapeutics | 1.90B |
| Tyra Biosciences | 1.90B |
| Monte Rosa Therapeutics | 1.88B |